Kotak Mahindra Mutual Fund
When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (Nifty Healthcare Index (Total Return Index)) is not available to us as a series.
This is an IDCW (dividend) option: it pays cash out of its NAV, so returns computed from the NAV alone would understate what an investor earned. See the Growth option of the same plan for performance.
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. Shown from the Direct plan of this fund, which holds the same portfolio. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. | Healthcare | 13.96% | — | 143.5 |
| Divis Laboratories Ltd. | Healthcare | 9.25% | — | 83.0 |
| TORRENT PHARMACEUTICALS LTD. | Healthcare | 4.75% | — | 77.7 |
| MOLBIO DIAGNOSTICS LIMITED | Healthcare | 4.53% | — | — |
| Max Healthcare Institute Ltd. | Healthcare | 4.34% | — | 124.3 |
| Ami Organics Ltd | Healthcare | 3.91% | — | 64.3 |
| Cipla Ltd. | Healthcare | 3.67% | — | 35.1 |
| PARK MEDI WORLD LIMITED (PARK HOSPITAL) | Healthcare | 3.36% | — | — |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 3.25% | — | 73.1 |
| YATHARTH HOSPITAL AND TRAUMA CARE SERVICES LTD | Healthcare | 3.25% | — | 100.2 |
| Gland Pharma Limited | Healthcare | 3.04% | — | 34.4 |
| SAI LIFE SCIENCES LIMITED | Healthcare | 3.04% | — | 89.9 |
| Fortis Healthcare India Ltd | Healthcare | 2.95% | — | 255.5 |
| MANKIND PHARMA LTD | Healthcare | 2.84% | — | 46.9 |
| Marksans Pharma Ltd | Healthcare | 2.51% | — | 46.8 |
| Laurus Labs Ltd | Healthcare | 2.49% | — | 122.0 |
| KRISHNA INSTITUTE OF MEDICAL | Healthcare | 2.46% | — | 105.1 |
| RUBICON RESEARCH LIMITED | Healthcare | 2.37% | — | 111.0 |
| ANTHEM BIOSCIENCES LTD | Healthcare | 2.33% | — | 76.6 |
| Ajanta Pharma Ltd. | Healthcare | 2.11% | — | 43.2 |
| VIYASH SCIENTIFIC LTD | Healthcare | 2.01% | — | 161.3 |
| Triparty Repo | — | 1.77% | — | — |
| ORCHID PHARMA LIMITED | Healthcare | 1.64% | — | 143.5 |
| CORONA REMEDIES LIMITED | Healthcare | 1.60% | — | 62.6 |
| Aurobindo Pharma Ltd. | Healthcare | 1.57% | — | 37.5 |
| EMCURE PHARMACEUTICALS LIMITED | Healthcare | 1.57% | — | 45.3 |
| JUBILANT INGREVIA LTD. | Chemicals | 1.49% | — | 30.0 |
| RAINBOW CHILDRENS MEDICARE LTD | Healthcare | 1.29% | — | 51.3 |
| Pfizer Ltd. | Healthcare | 1.16% | — | 23.9 |
| JUBILANT PHARMOVA LIMITED | Healthcare | 1.15% | — | 677.0 |
| Lupin Ltd. | Healthcare | 1.14% | — | 13.2 |
| METROPOLIS HEALTHCARE LTD. | Healthcare | 1.14% | — | 28.1 |
| Zydus Lifesciences Ltd. | Healthcare | 1.13% | — | 32.6 |
| DR.Lal Pathlabs Ltd | Healthcare | 1.11% | — | 38.4 |
| INNOVA CAPTABS LTD | Healthcare | 1.08% | — | 68.7 |
| LAXMI DENTAL LIMITED | Healthcare | 0.17% | — | 59.2 |
This is a paid feature
Comparing more months of this fund's own portfolio history is available on paid plans.
Sign inExpense ratio by month: Oct 25 0.76% · Nov 25 0.74% · Dec 25 0.74% · Jan 26 0.74% · Feb 26 0.74% · Mar 26 0.74% · Apr 26 0.91% · May 26 0.87% · Jun 26 1.04% · Jul 26 1.09% · Aug 26 1.09% · Sep 26 1.04%
For redemption / switch out within 30 days from the date of allotment: 0.5% If units are redeemed or switched out on or after 30 days from the date of allotment: NIL Units issued on reinvestment of IDCW shall not be subject to entry and exit load. Any exit load charged (net off Goods and Services tax, if any) shall be credited back to the Scheme.
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors. However, there is no assurance that the objective of the scheme will be achieved .
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
